NCT06315790View on ClinicalTrials.gov

Safety and Efficacy of Botulinum Toxin A in Patients With Trigeminal Neuralgia

PHASE3RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Trigeminal Neuralgia
Interventions
DRUG

Botulinum toxin A

Subcutaneously injections are given unilaterally in the face at predefined injection sites.

OTHER

Isotonic saline

Subcutaneously injections are given unilaterally in the face at predefined injection sites.

Trial Locations (1)

2600

RECRUITING

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Henrik Schytz

OTHER